HeartBeam Seeks Shareholder Approval for 6% Equity Plan Dilution to Fund Compensation Amidst Going Concern
BEAT sits 39% above its 52-week low of $0.54.
Summary
HeartBeam, Inc. filed its definitive proxy statement for its annual meeting, seeking shareholder approval to increase its equity incentive plan by 3 million shares, representing a potential 6% dilution, to support compensation and conserve cash.
Key Events · Corporate Governance and Compliance · BEAT
-
Annual Shareholder Meeting Scheduled
The company will hold its 2026 Annual Meeting of Shareholders virtually on July 31, 2026.
-
Proposed Equity Plan Expansion
Shareholders will vote on amending the 2022 Equity Incentive Plan to increase authorized shares by 3,000,000, which would result in a potential additional dilution of 6%.
-
Equity Compensation Strategy
The proposed increase supports the company's strategy of using equity grants in lieu of cash for executive and director compensation, a critical measure for cash conservation given the reiterated 'going concern' warning.
-
Compliance Issues Noted
The filing discloses that several directors and officers had late Form 4 filings in 2025 related to stock dispositions and equity grants.
Analysis · BEAT · Industrial Applications And Services
HeartBeam, Inc. is asking shareholders to approve an amendment to its 2022 Equity Incentive Plan to increase authorized shares by 3,000,000. This represents a potential additional dilution of 6% to existing shareholders. While dilutive, this move is critical for the company to continue using equity compensation for executives and directors, a strategy already employed in 2025 to conserve cash. This is particularly important given the company's reiterated 'going concern' warning, as it provides a mechanism to retain talent without further straining liquidity. The filing also notes several late Form 4 filings by directors and officers in 2025, indicating compliance oversight issues.
How filings like this one have moved
In the 30 days to Oct 4, 2026, 29.2% of the 1581 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.60%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, BEAT was trading at $0.75 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $42.2M. The 52-week trading range was $0.54 to $4.00. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.